285 related articles for article (PubMed ID: 8815575)
1. Elevated levels of prothrombin activation fragment 1 + 2 in plasma from patients with heterozygous Arg506 to Gln mutation in the factor V gene (APC-resistance) and/or inherited protein S deficiency.
Zöller B; Holm J; Svensson P; Dahlbäck B
Thromb Haemost; 1996 Feb; 75(2):270-4. PubMed ID: 8815575
[TBL] [Abstract][Full Text] [Related]
2. New molecular insights into the genetics of thrombophilia. Resistance to activated protein C caused by Arg506 to Gln mutation in factor V as a pathogenic risk factor for venous thrombosis.
Dahlbäck B
Thromb Haemost; 1995 Jul; 74(1):139-48. PubMed ID: 8578447
[TBL] [Abstract][Full Text] [Related]
3. Thrombophilia as a multigenic disease.
Zöller B; García de Frutos P; Hillarp A; Dahlbäck B
Haematologica; 1999 Jan; 84(1):59-70. PubMed ID: 10091393
[TBL] [Abstract][Full Text] [Related]
4. Resistance to activated protein C due to mutated factor V as a novel cause of inherited thrombophilia.
De Stefano V; Leone G
Haematologica; 1995; 80(4):344-56. PubMed ID: 7590506
[TBL] [Abstract][Full Text] [Related]
5. Activated protein C resistance and thrombosis: molecular mechanisms of hypercoagulable state due to FVR506Q mutation.
Dahlbäck B
Semin Thromb Hemost; 1999; 25(3):273-89. PubMed ID: 10443959
[TBL] [Abstract][Full Text] [Related]
6. Heightened thrombin generation in individuals with resistance to activated protein C.
Martinelli I; Bottasso B; Duca F; Faioni E; Mannucci PM
Thromb Haemost; 1996 May; 75(5):703-5. PubMed ID: 8725708
[TBL] [Abstract][Full Text] [Related]
7. Association of elevated levels of prothrombin fragment 1+2 and Arg506 to Gln mutation in patients with a history of ischemic stroke.
De Lucia D; Papa ML; Ammendola F; Pezzella S; Del Giudice V; Marotta R; Renis V; Di Mauro C; Maisto G; Masi S; Nina P; Franco A; Schisano G
J Neurosurg Sci; 1999 Mar; 43(1):45-50; discussion 50-1. PubMed ID: 10494665
[TBL] [Abstract][Full Text] [Related]
8. Homozygous APC-resistance combined with inherited type I protein S deficiency in a young boy with severe thrombotic disease.
Zöller B; He X; Dahlbäck B
Thromb Haemost; 1995 May; 73(5):743-5. PubMed ID: 7482396
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic APC resistance as a marker of hypercoagulability in primitive cerebral lymphoma.
De Lucia D; De Francesco F; Marotta R; Maisto G; Meo D; Sessa M; Misso M; Galante M; Russo T; Pignalosa O; Napolitano M; Papa ML; Niglio A; Di Micco P
Exp Oncol; 2005 Jun; 27(2):159-61. PubMed ID: 15995637
[TBL] [Abstract][Full Text] [Related]
10. Resistance to activated protein C caused by the R506Q mutation in the gene for factor V is a common risk factor for venous thrombosis.
Dahlbck B
J Intern Med Suppl; 1997; 740():1-8. PubMed ID: 9350175
[TBL] [Abstract][Full Text] [Related]
11. Factor V Leiden: an additional risk factor for thrombosis in protein S deficient families?
Koeleman BP; van Rumpt D; Hamulyák K; Reitsma PH; Bertina RM
Thromb Haemost; 1995 Aug; 74(2):580-3. PubMed ID: 8584987
[TBL] [Abstract][Full Text] [Related]
12. Activated protein C resistance--a major risk factor for thrombosis.
Rosén SB; Sturk A
Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
[TBL] [Abstract][Full Text] [Related]
13. Activated protein C resistance: molecular mechanisms.
Griffin JH; Heeb MJ; Kojima Y; Fernández JA; Kojima K; Hackeng TM; Greengard JS
Thromb Haemost; 1995 Jul; 74(1):444-8. PubMed ID: 8578503
[TBL] [Abstract][Full Text] [Related]
14. Resistance to activated protein C as risk factor for thrombosis: molecular mechanisms, laboratory investigation, and clinical management.
Dahlbäck B
Semin Hematol; 1997 Jul; 34(3):217-34. PubMed ID: 9241707
[TBL] [Abstract][Full Text] [Related]
15. Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test.
Curvers J; Thomassen MC; Rimmer J; Hamulyak K; van der Meer J; Tans G; Preston FE; Rosing J
Thromb Haemost; 2002 Jul; 88(1):5-11. PubMed ID: 12152677
[TBL] [Abstract][Full Text] [Related]
16. Ischaemic stroke in infancy and childhood: role of the Arg506 to Gln mutation in the factor V gene.
Nowak-Göttl U; Sträter R; Dübbers A; Oleszuk-Raschke K; Vielhaber H
Blood Coagul Fibrinolysis; 1996 Oct; 7(7):684-8. PubMed ID: 8958390
[TBL] [Abstract][Full Text] [Related]
17. [Resistance to activated protein C. The most common cause of familial thrombophilia].
Larsen TB; Ravn HB; Lassen JF; Lund ED; Brandslund I
Ugeskr Laeger; 1996 Nov; 158(46):6584-8. PubMed ID: 8966822
[TBL] [Abstract][Full Text] [Related]
18. Activated protein C resistance and the FV:R506Q mutation in a random population sample--associations with cardiovascular risk factors and coagulation variables.
Lowe GD; Rumley A; Woodward M; Reid E; Rumley J
Thromb Haemost; 1999 Jun; 81(6):918-24. PubMed ID: 10404768
[TBL] [Abstract][Full Text] [Related]
19. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C.
Zöller B; Svensson PJ; He X; Dahlbäck B
J Clin Invest; 1994 Dec; 94(6):2521-4. PubMed ID: 7989612
[TBL] [Abstract][Full Text] [Related]
20. Factor V and protein S as cofactors to activated protein C.
Dahlbäck B
Haematologica; 1997; 82(1):91-5. PubMed ID: 9107093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
